GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Dabomb Protein Biotech Corp (ROCO:6578) » Definitions » Additional Paid-In Capital

Dabomb Protein Biotech (ROCO:6578) Additional Paid-In Capital : NT$355.2 Mil(As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Dabomb Protein Biotech Additional Paid-In Capital?


Dabomb Protein Biotech's quarterly additional paid-in capital increased from Sep. 2024 (NT$331.5 Mil) to Dec. 2024 (NT$355.2 Mil) but then stayed the same from Dec. 2024 (NT$355.2 Mil) to Mar. 2025 (NT$355.2 Mil).

Dabomb Protein Biotech's annual additional paid-in capital increased from Dec. 2022 (NT$286.3 Mil) to Dec. 2023 (NT$344.5 Mil) and increased from Dec. 2023 (NT$344.5 Mil) to Dec. 2024 (NT$355.2 Mil).

Dabomb Protein Biotech Additional Paid-In Capital Historical Data

The historical data trend for Dabomb Protein Biotech's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dabomb Protein Biotech Additional Paid-In Capital Chart

Dabomb Protein Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 252.73 246.90 286.31 344.46 355.25

Dabomb Protein Biotech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 361.18 327.76 331.50 355.25 355.25

Dabomb Protein Biotech Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Dabomb Protein Biotech Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Dabomb Protein Biotech's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Dabomb Protein Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Dabomb Protein Biotech Corp (ROCO:6578) » Definitions » Additional Paid-In Capital
Comparable Companies
ROCO:6886 ROCO:6929 ROCO:6963 ROCO:4109 ROCO:1294 ROCO:2756 TPE:1220 ROCO:6968 TPE:1233 ROCO:1271 XSWX:NESN XPAR:BN SHSE:603288 KHC GIS K NSE:NESTLEIND SHSE:600887 TSE:2802 SZSE:300999
Traded in Other Exchanges
N/A
Address
52,Gungye 3rd Road, Annan District, Tainan, TWN, 709
Website
https://www.dabombprotein.com
Dabomb Protein Biotech Corp is engaged in the manufacture, wholesale, and sale of hydrolyzed soy protein. Its products include Plant protein, Antibiotics alternatives, Pet care, Core technology, and CDMO(ODM/OEM). It operates in a single segment engaged in the manufacture, wholesale and sales of hydrolysed soy protein. Geographically it operates in Malaysia, Taiwan, USA, China, Vietnam, and Others with majority of the revenue deriving from Vietnam.

Dabomb Protein Biotech Headlines

No Headlines